- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
BAFNA Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The unaudited results have been published in ‘Business Standard’ and ‘Makkal Kural’. This update highlights the company’s performance and may influence investor sentiment by signaling operational insights and future strategies. Investors may perceive this as a potential risk or opportunity, depending on the results disclosed and the overall market response. The company continues to focus on transparency with its stakeholders.